Rockin Robin SongFlying The Web For News.
RobinPost Logo Amazon Prime Deals





Consumer Daily Reports

GOP lawmakers preparing to overturn Biden-era rule that protected consumers

By James R. Hood of ConsumerAffairs
March 26, 2025

Key Points

  • Senate Republicans introduced a resolution to nullify a CFPB rule banning medical debt from credit reports.

  • Critics say the rule exceeds the CFPBs authority and could limit consumer access to credit.

  • The rule is also facing legal challenges from credit industry and debt collection groups.

Details

Republican lawmakers in Congress are pushing to overturn a new rule from theConsumer Financial Protection Bureau (CFPB)that bansmedical debt from appearing on credit reportsand restricts its use in lending decisions.

Sen. Mike Rounds (R-S.D.)has introducedS.J. Res. 36, aCongressional Review Act (CRA)resolution aimed at nullifying the rule, which was finalized by the CFPB onJanuary 7, 2025, just days before President Biden left office. The resolution is cosponsored bySen. Tim Scott (R-S.C.), chairman of the Senate Banking Committee.

The CFPB going beyond their statutory authority to eliminate all medical debt from credit reports is irresponsible and a clear example of regulatory overreach, Rounds said. He warned that the rule could lead to banks having a less clear credit picture and limit access to credit for consumers.

Acompanion resolution,H.J. Res. 74, has been introduced in the House byRep. Ralph Norman (R-S.C.).

Sen. Scott echoed those concerns, stating that while medical debt is a serious issue, this rule will do nothing to address the underlying issues. Instead, it will reduce access to credit and important health care services for those most in need.

The rule was finalized in January 2025 as the CFPB was preparing to pack up and turn over its operations to the incoming Trump Administration.

"People who get sick shouldn't have their financial future upended," CFPB Director Rohit Chopra said in announcing the new rules in January. "The CFPB's final rule will close a special carveout that has allowed debt collectors to abuse the credit reporting system to coerce people into paying medical bills they may not even owe."

Rule faces legal challenges

The CFPB rule is also being challenged in court. Two separate lawsuits have been filed in federal courts in Texas:

  • TheConsumer Data Industry Association (CDIA)and theCornerstone Credit Union Leaguefiled the first suit, claiming the ruleplainly exceeds the CFPBs legal authorityunder theFair Credit Reporting Act.

  • A second suit byACA International, a debt collection industry group, andSpecialized Collection Services Inc., argues the CFPB is exploiting public frustration with medical bills to issue a politically motivated regulation.

Both suits contend the CFPB lacks both the legal authority and the healthcare expertise to impose such restrictions and argue the rule is based more on politics than policy.

The CFPB has not yet publicly responded to the congressional resolutions or the lawsuits.

Sign up below for The Daily Consumer, our newsletter on the latest consumer news, including recalls, scams, lawsuits and more.




Posted: 2025-03-26 22:26:45

Get Full News Story On Consumer Affairs



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



More News From This Category
Consumer News: Gasoline prices appear to be headed higher
Wed, 18 Feb 2026 20:07:07 +0000

But theyre still cheaper than a year ago

By Mark Huffman of ConsumerAffairs
February 18, 2026
  • The nations average price of gasoline has risen 2.6 cents over the last week and stands at $2.84 per gallon, according to GasBuddydata compiled from more than 12 million individual price reports covering over 150,000 gas stations across the country.

  • The national average is up 4.9 cents from a month ago and is 24.5 cents per gallon lower than a year ago.

  • The national average price of diesel rose 1.0 centin the last week and stands at $3.624 per gallon.


Gasoline prices are beginning to rise again as seasonal factors and refinery maintenance begin to influence the market, but prices are still lower than they were 12 months ago. Industry analysts say broader oil market dynamics remain relatively stable.

The national average price of gasoline continues to grind higher, and while the pace of increases remains modest for now, upward momentum could accelerate in the coming weeks as refinery maintenance intensifies and the broader transition to summer gasoline begins, Patrick De Haan, head of petroleum analysis at GasBuddy, said in this weeks GasBuddy blog.

However, supply-side dynamics could temper that seasonal pressure. If OPEC+ proceeds with resuming production increases following its first-quarter pause, additional barrels could cap crude oils upside and limit the magnitude of the spring rally at the pump. That said, geopolitical tensions particularly between the U.S. and Iran remain an unpredictable variable, injecting risk into the outlook and leaving prices vulnerable to sudden shifts.

Oil markets await clarity

DeHaan says crude oil prices were largely range-bound over the past week as traders monitored nuclear negotiations between the United States and Iran. Early Monday trading showed West Texas Intermediate crude up ninecents at $62.98 per barrel, slightly below last Mondays $63.58 opening. Brent crude also rose ninecents to $67.84 per barrel, down from $68.07 a week earlier.

Oil prices have found support from relatively modest inventory builds so far this year. At the same time, expectations of rising output from OPEC+ and non-OPEC producers are limiting further gains.

According to the Energy Information Administrations Weekly Petroleum Status Report for the week ending February 6, 2026, U.S. crude oil inventories rose by 8.5 million barrels and sit about 3% below the seasonal average. The Strategic Petroleum Reserve remained unchanged at 415.2 million barrels.

Plenty of supply

Gasoline inventories increased by 1.2 million barrels and are about 4% above the five-year seasonal average. Distillate inventories, which include diesel, fell by 2.7 million barrels and are roughly 4% below the five-year average.

Refinery utilization slipped onepercentage point to 89.4%, while implied gasoline demand a proxy for retail consumption rose by 147,000 barrels per day to 8.3 million barrels per day. The decline in refinery runs, combined with the seasonal shift toward summer-blend gasoline, could add upward pressure to pump prices in the weeks ahead.

What drivers are paying

The most common price motorists encountered last week was $2.79 per gallon, up 20 cents from the prior week. Other frequently reported prices included $2.89, $2.69, $2.59, and $2.99 per gallon.

The median U.S. gas price stands at $2.77 per gallon, about 10 cents lower than the national average. Prices vary widely: the top 10% of stations average $4.25 per gallon, while the bottom 10% average $2.28.

Oklahoma has the nations lowest statewide average at $2.25 per gallon, followed by Arkansas and Louisiana at $2.43. California continues to post the highest average at $4.50 per gallon, with Hawaii at $4.33 and Washington at $4.07.

Among weekly movers, Michigan saw the largest jump, with prices rising 12.1 cents. Oregon was up 10.1 cents. Meanwhile, Iowa (-9.3 cents), Utah (-8.5 cents), and New Mexico (-8.1 cents) posted the biggest declines.


Read More ...


Consumer News: Bayer proposes a $7.25 billion Roundup settlement
Wed, 18 Feb 2026 20:07:07 +0000

The company has already paid out billions in other lawsuits

By Mark Huffman of ConsumerAffairs
February 18, 2026
  • Bayer has outlined a new proposal aimed at resolving thousands of remaining Roundup cancer claims in U.S. courts.

  • The plan seeks to limit future liability while providing compensation to current claimants through a structured settlement framework.

  • Plaintiffs attorneys and consumer advocates say key legal and scientific questions remain unresolved.


Bayer is advancing a renewed effort to contain its long-running legal battle over allegations that its Roundup weedkiller causes cancer, unveiling a proposal designed to settle a substantial portion of outstanding claims while establishing limits for future litigation.

The German pharmaceutical and agricultural giant has been grappling with lawsuits tied to glyphosate, Roundups active ingredient, since acquiring Monsanto in 2018 the company that owned Roundup.

Tens of thousands of plaintiffs have alleged that exposure to the herbicide led to non-Hodgkins lymphoma. Bayer has consistently denied that glyphosate is carcinogenic, citing regulatory assessments in the United States and abroad that found the chemical safe when used as directed.

Structured resolution process

Under the latest proposal, Bayer aims to create a structured resolution process for pending cases that have not yet gone to trial or been settled individually. According to company statements, the framework would provide compensation tiers based on medical history, duration of exposure and other risk factors.

The company is also seeking judicial approval for mechanisms that would help manage or limit future claims, potentially through class-based agreements or scientific review panels. It has proposed paying a settlement of $7.25 billion.

Bayer has already paid billions of dollars to resolve earlier waves of litigation, but thousands of cases remain active in state and federal courts. Several high-profile jury verdicts in recent years have awarded substantial damages to plaintiffs, though some awards were later reduced on appeal.

A balancing act

Legal analysts say the companys strategy reflects a balancing act: resolving uncertainty for investors while avoiding admission of liability or setting precedents that could invite additional claims.

Plaintiffs lawyers have expressed cautious skepticism. Some argue that any broad settlement must ensure adequate compensation for individuals with severe diagnoses and allow room for emerging scientific evidence. Others have raised concerns about proposals that could limit access to jury trials for future claimants.

Consumer advocates note that the litigation has unfolded amid ongoing scientific debate. While the U.S. Environmental Protection Agency has maintained that glyphosate is unlikely to pose a cancer risk to humans when used properly, the International Agency for Research on Cancer classified the chemical in 2015 as probably carcinogenic to humans, a determination that helped fuel the wave of lawsuits.


Read More ...


Consumer News: That Amazon 'recall alert' text? It’s probably a scam
Wed, 18 Feb 2026 20:07:07 +0000

How to protect your Amazon account from fake recall alerts

By Kyle James of ConsumerAffairs
February 18, 2026
  • The text claims a recent Amazon order was recalled and links to a very real-looking (but fake) sign-in page.

  • Recall messages create panic so youll click fast. Legitimate recalls show up inside your Amazon account and never through random text links.

  • Never click the link. Open the Amazon app directly, check your orders, and verify any recall there.


If you recently received a text saying, Your Amazon order has been recalled, be sure you dont click on anything.

Cybersecurity experts say a new wave of phishing is targeting Amazon customers by impersonating official product recall alerts. According to Guardio, scammers are sending highly convincing text messages that claim a recent purchase has been included in an official recall.

The goal isnt to warn you, but rather to steal your Amazon login.

How the scam works

The text typically includes the following:

  • References a recent order.
  • Claims the item has been recalled for safety reasons.
  • Includes a link to start your refund or view recall details."

That link leads to a very real-looking, but completely fake, Amazon login page.

Once you enter your email and password, the scammers can then hijack your account. At which point they can change your password and potentially access your stored payment methods.

The pages often look nearly identical to Amazons real website, which is why this scam is catching people off guard.

Why this tactic is effective

Scammers know that recall notices create urgency and are fairly common these days.

If you think you bought a dangerous product, especially something like electronics, appliances, or childrens items, youre more likely to tap the text and login.

The usual suspects for these are ploys like delivery delays, account suspensions, and refund problems. All things that create some fear and urgency in Amazon shoppers. So, it makes sense that a product recall message would fit right into that playbook.

What Amazon says to all of this

Amazon states it will never ask for your sensitive information, which includes:

  • Your password
  • One-time passcodes
  • Full payment details
  • Gift card codes

And most importantly, Amazon will NEVER request any information outside of its official website or mobile app.

The company also encourages customers to report suspicious messages so they can investigate and shut down any phishing networks. In 2024 alone, Amazon says it helped take down more than 55,000 phishing websites and 12,000 scam-related phone numbers.

How to verify a recall safely

If you get a recall text, its smart to follow these steps:

  1. Do not click the link.
  2. Open the official Amazon app or manually type Amazon.com into your browser.
  3. Log in and check your recent orders.
  4. Look for recall notifications directly within your account.
  5. Contact Amazon Customer Service through the official site if youre unsure.

If theres a legitimate recall, it will appear in your account order history or through official communication channels inside the app.

The bottom line

Product recalls happen all the time, but legitimate recall notices wont demand your password by text message.

But the red flag should be raised when a text message pressures you to click fast and enter account details. Always slow down, verify inside the app, and assume any unsolicited recall text is fake until proven legitimate.

A few extra seconds of caution can save you from losing access to your account and potentially your money.


Read More ...


Consumer News: Judge tosses lawsuit against Buffalo Wild Wings ‘boneless wings’
Wed, 18 Feb 2026 20:07:06 +0000

The plaintiff argued that the name was false advertising

By Mark Huffman of ConsumerAffairs
February 18, 2026
  • A federal judge has dismissed a lawsuit alleging that Buffalo Wild Wings falsely advertised its boneless wings.

  • The court ruled that reasonable consumers understand boneless wings to be a style of preparation, not a literal claim about deboned chicken wings.

  • The decision reinforces prior rulings that common food terms are judged by everyday understanding, not strict literal interpretation.


A federal judge has dismissed a proposed class-action lawsuit accusing Buffalo Wild Wings of false advertising over its popular boneless wings, ruling that the menu items name would not mislead a reasonable consumer.

In a decision issued this week, U.S. District Judge John Tharp concluded that the term boneless wings describes a cooking style rather than a guarantee that the product is derived from a deboned chicken wing. The plaintiff had argued that the menu item made from breaded, sauced chunks of chicken breast meat was misleading because it does not consist of actual chicken wings with bones removed.

No reasonable consumer would believe that boneless wings are wings that have simply had their bones extracted, the judge wrote in the opinion. Instead, the court said, the phrase has become widely understood in American dining culture to refer to bite-sized pieces of white meat chicken prepared in the style of traditional wings.

The complaint

The lawsuit, filed in 2025, claimed that Buffalo Wild Wings marketing and menu descriptions deceived customers into thinking they were ordering deboned wings rather than what the complaint characterized as chicken nuggets. The plaintiff sought damages and injunctive relief on behalf of similarly situated customers nationwide.

Attorneys for Buffalo Wild Wings countered that the term boneless wings has been used for decades across the restaurant industry and is commonly understood to distinguish the product from traditional bone-in wings. They argued that the claim relied on an overly literal reading of the menu.

The court agreed with the restaurant chain, comparing the naming dispute to other food items whose names do not strictly describe their ingredients or form. The opinion referenced examples such as chicken fingers and hamburgers, noting that consumers do not expect those products to contain fingers or ham.

Reasonable consumer standard

Legal analysts say the ruling fits within a broader trend of courts dismissing consumer protection lawsuits that hinge on hyper-literal interpretations of food labeling.

Some legal analysts have noted that judges generally apply a reasonable consumerstandard in these types of lawsuits. They pose the question of whether an ordinary consumer would actually be misled, not whether a term could be dissected into a technically inaccurate meaning.

Buffalo Wild Wings, headquartered in Atlanta and owned by Inspire Brands, welcomed the decision. In a statement, the company said it was pleased the court recognized that its menu descriptions are clear and consistent with industry norms.

Our guests understand that boneless wings are made from premium white meat chicken and prepared in the flavor styles they love, the statement said.


Read More ...


Consumer News: Bayer proposes a $7.25 billion Roundup settlement
Wed, 18 Feb 2026 17:07:06 +0000

The company has already paid out billions in other lawsuits

By Mark Huffman of ConsumerAffairs
February 18, 2026
  • Bayer has outlined a new proposal aimed at resolving thousands of remaining Roundup cancer claims in U.S. courts.

  • The plan seeks to limit future liability while providing compensation to current claimants through a structured settlement framework.

  • Plaintiffs attorneys and consumer advocates say key legal and scientific questions remain unresolved.


Bayer is advancing a renewed effort to contain its long-running legal battle over allegations that its Roundup weedkiller causes cancer, unveiling a proposal designed to settle a substantial portion of outstanding claims while establishing limits for future litigation.

The German pharmaceutical and agricultural giant has been grappling with lawsuits tied to glyphosate, Roundups active ingredient, since acquiring Monsanto in 2018 the company that owned Roundup.

Tens of thousands of plaintiffs have alleged that exposure to the herbicide led to non-Hodgkin lymphoma. Bayer has consistently denied that glyphosate is carcinogenic, citing regulatory assessments in the United States and abroad that found the chemical safe when used as directed.

Structured resolution process

Under the latest proposal, Bayer aims to create a structured resolution process for pending cases that have not yet gone to trial or been settled individually. According to company statements, the framework would provide compensation tiers based on medical history, duration of exposure and other risk factors.

The company is also seeking judicial approval for mechanisms that would help manage or limit future claims, potentially through class-based agreements or scientific review panels. It has proposed paying a settlement of $7.25 billion.

Bayer has already paid billions of dollars to resolve earlier waves of litigation, but thousands of cases remain active in state and federal courts. Several high-profile jury verdicts in recent years have awarded substantial damages to plaintiffs, though some awards were later reduced on appeal.

A balancing act

Legal analysts say the companys strategy reflects a balancing act: resolving uncertainty for investors while avoiding admission of liability or setting precedents that could invite additional claims.

Plaintiffs lawyers have expressed cautious skepticism. Some argue that any broad settlement must ensure adequate compensation for individuals with severe diagnoses and allow room for emerging scientific evidence. Others have raised concerns about proposals that could limit access to jury trials for future claimants.

Consumer advocates note that the litigation has unfolded amid ongoing scientific debate. While the U.S. Environmental Protection Agency has maintained that glyphosate is unlikely to pose a cancer risk to humans when used properly, the International Agency for Research on Cancer classified the chemical in 2015 as probably carcinogenic to humans, a determination that helped fuel the wave of lawsuits.


Read More ...


Related Bing News Results
Ninety years of Consumer Reports on display at Duke
Tue, 17 Feb 2026 20:41:00 GMT
The Consumer Reports Archives,” taps the rich, 2000 linear feet long Consumer Reports’ archive to tell the story of how this organization came to be, what it has done and why.

5 Cheap Cars Actually Worth Buying, According To Consumer Reports
Mon, 16 Feb 2026 06:17:00 GMT
New cars under $20,000 are gone for 2026, but there are solid picks if you know where to look. These Consumer Reports choices focus on value and longevity.

Consumer Reports shares the best February deals on appliances, electronics
Mon, 09 Feb 2026 23:29:00 GMT
From Presidents Day sales to post-holiday price drops, Consumer Reports says shoppers can find several smart buys.

Consumer Reports' top 10 vehicles for 2026 — see which cars made the list
Wed, 04 Feb 2026 14:40:11 GMT
For the first time, the top 10 cars on Consumer Reports' annual list of best new vehicles also include electric or hybrid models.

Consumer Reports tests more protein powders for lead
Mon, 26 Jan 2026 15:41:00 GMT
DENVER — Last fall, Consumer Reports tested dozens of protein powders and ready-to-drink shakes. What the lab found raised red flags: more than two-thirds contained more lead in one serving than CR’s ...


Blow Us A Whistle


Related Product Search/Búsqueda de productos relacionados

Amazon Logo

Visit Our New Print-On-Demand Stores On Printify and Zazzle
Printify Zazzle